Peter Mol
36PUBLICATIONS
115CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (36)
Sort by Publication Date:
|Apr 04, 2026
A Cross-Sectional Survey of Evidence Needs for Medicinal Products in Europe With a Focus on Real-World Evidence.Maria Melinder, Fabian Windfuhr, Tanja Dahlqvist
|Mar 18, 2026
A target trial emulation of the CONFIRM study with an extension to subgroups: an example for relapsing-remitting multiple sclerosis.Stefan Verweij, Maarten J Bijlsma, Katrien Oude Rengerink
|Feb 13, 2026
More Than a Question of Correlation: Characterization of the Evidentiary Basis for Biomarker Surrogates Used in European Marketing Authorizations.Renske Johanna Grupstra, Viktoriia Starokozhko, Elisabeth Bakker
|Feb 11, 2026
Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World Data.Francesco Pignatti, Tarec Christoffer El-Galaly, Martin Kaiser
|Oct 09, 2025
The European Medicines Agency's review of elexacaftor/tezacaftor/ivacaftor: extending its use to all people with cystic fibrosis aged 2 years and older who do not have two class I <i>CFTR</i> variants.Catherine Drai, Hanneke J van der Woude, Anne J Lexmond
|Aug 26, 2025
Real-World Data Included in Post-authorisation Measures: A Case Study of Approved Advanced Therapy Medicinal Products in the European Union between 2013 and 2024.Diogo Almeida, Diana Mandslay, Peter G M Mol
Pageof 6
Frequent Collaborators
14 joint publications
Sieta T de Vries
10 joint publications
Petra Denig
5 joint publications
Bruno Sepodes
5 joint publications
Elisabeth Bakker
4 joint publications
Anna Maria Gerdina Pasmooij
4 joint publications
Carla Torre
4 joint publications
Esther de Vries
3 joint publications
Eugène P van Puijenbroek
3 joint publications
Patrice Verpillat
3 joint publications
Carla Jonker
